Lozol and Benicar drug interactions - a phase IV clinical study of FDA data
Drug interactions are reported among people who take Lozol and Benicar. Common interactions include feeling jittery among females and cough among males.
The phase IV clinical study analyzes what interactions people who take Lozol and Benicar have. It is created by eHealthMe based on reports of 25 people who take Lozol and Benicar from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
25 people who take Lozol and Benicar together, and have interactions are studied.
What is Lozol?
Lozol has active ingredients of indapamide. It is often used in high blood pressure. eHealthMe is studying from 1,637 Lozol users for its effectiveness, alternative drugs and more.
What is Benicar?
Benicar has active ingredients of olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 34,937 Benicar users for its effectiveness, alternative drugs and more.
Number of Lozol and Benicar reports submitted per year:
Common Lozol and Benicar drug interactions by gender *:
- Feeling jittery
- Affect lability
- Angioneurotic oedema
- Blood glucose decreased
- Chronic kidney disease
- Atrial fibrillation
- Cardiac failure congestive
- Carotid artery stenosis
- Cerebrovascular accident
- Faeces discoloured
Common Lozol and Benicar drug interactions by age *:
- Abdominal discomfort
- Euphoric mood
- Feeling jittery
- Muscular weakness
- Musculoskeletal pain
- Renal failure
Common conditions people have *:
- Type 2 Diabetes: 3 people, 12.00%
- High Blood Cholesterol: 3 people, 12.00%
- Bipolar Disorder (mood disorder): 3 people, 12.00%
- Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 2 people, 8.00%
- Sinusitis (inflammation of sinus): 2 people, 8.00%
- Quit Smoking: 2 people, 8.00%
- Pneumonia: 2 people, 8.00%
- Pain: 2 people, 8.00%
- Hypersensitivity: 2 people, 8.00%
- Herpes Simplex (herpes simplex is a common viral infection): 2 people, 8.00%
* Approximation only. Some reports may have incomplete information.
Do you take Lozol and Benicar?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of the 2 drugs:
Browse all drug interactions of Lozol and Benicar:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Lozol interactions:
- Lozol and Aspirin: 123 reports
- Lozol and Glucophage: 116 reports
- Lozol and Lipitor: 155 reports
- Lozol and Norvasc: 155 reports
- Lozol and Premarin: 127 reports
- Lozol and Prilosec: 185 reports
- Lozol and Synthroid: 166 reports
- Lozol and Vioxx: 115 reports
- Lozol and Zocor: 109 reports
Browse all interactions between Lozol and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Benicar interactions:
Browse all interactions between Benicar and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
How the study uses the data?
The study uses data from the FDA. It is based on indapamide and olmesartan medoxomil (the active ingredients of Lozol and Benicar, respectively), and Lozol and Benicar (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Lozol and Benicar.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Breast Cancer and Heart Palpitations - now
- Aviane-28 and Remicade drug interaction - 5 seconds ago
- Patanol vs. Nasacort - 6 seconds ago
- Cefepime Hydrochloride and Metformin Hydrochloride drug interaction - 8 seconds ago
- Diovan Hct vs. Nifedipine - 20 seconds ago
- Coreg and Gastroesophageal Reflux Disease - 23 seconds ago
- Cefazolin and Tolterodine Tartrate drug interaction - 41 seconds ago
- Ongentys and Renal Failure Aggravated - 41 seconds ago
- Yasmin and Diamox drug interaction - 44 seconds ago
- Sutent and Fever - 51 seconds ago